Literature DB >> 23518505

PP2A(Cdc55) regulates G1 cyclin stability.

Paula McCourt1, Christina Gallo-Ebert, Yan Gonghong, Yu Jiang, Joseph T Nickels.   

Abstract

Maintaining accurate progression through the cell cycle requires the proper temporal expression and regulation of cyclins. The mammalian D-type cyclins promote G1-S transition. D1 cyclin protein stability is regulated through its ubiquitylation and resulting proteolysis catalyzed by the SCF E3 ubiquitin ligase complex containing the F-box protein, Fbx4. SCF E3-ligase-dependent ubiquitylation of D1 is trigged by an increase in the phosphorylation status of the cyclin. As inhibition of ubiquitin-dependent D1 degradation is seen in many human cancers, we set out to uncover how D-type cyclin phosphorylation is regulated. Here we show that in S. cerevisiae, a heterotrimeric protein phosphatase 2A (PP2A(Cdc55)) containing the mammalian PPP2R2/PR55 B subunit ortholog Cdc55 regulates the stability of the G1 cyclin Cln2 by directly regulating its phosphorylation state. Cells lacking Cdc55 contain drastically reduced Cln2 levels caused by degradation due to cdk-dependent hyperphosphorylation, as a Cln2 mutant unable to be phosphorylated by the yeast cdk Cdc28 is highly stable in cdc55-null cells. Moreover, cdc55-null cells become inviable when the SCF(Grr1) activity known to regulate Cln2 levels is eliminated or when Cln2 is overexpressed, indicating a critical relationship between SCF and PP2A functions in regulating cell cycle progression through modulation of G1-S cyclin degradation/stability. In sum, our results indicate that PP2A is absolutely required to maintain G1-S cyclin levels through modulating their phosphorylation status, an event necessary to properly transit through the cell cycle.

Entities:  

Keywords:  cell cycle; cyclin; phosphorylation; protein phosphatase; ubiquitin

Mesh:

Substances:

Year:  2013        PMID: 23518505      PMCID: PMC3674085          DOI: 10.4161/cc.24231

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  70 in total

Review 1.  Shugoshins: from protectors of cohesion to versatile adaptors at the centromere.

Authors:  Cristina Gutiérrez-Caballero; Luis R Cebollero; Alberto M Pendás
Journal:  Trends Genet       Date:  2012-04-27       Impact factor: 11.639

Review 2.  Protein phosphatases take the mitotic stage.

Authors:  Peter De Wulf; Francesca Montani; Rosella Visintin
Journal:  Curr Opin Cell Biol       Date:  2009-09-19       Impact factor: 8.382

Review 3.  Cyclin D as a therapeutic target in cancer.

Authors:  Elizabeth A Musgrove; C Elizabeth Caldon; Jane Barraclough; Andrew Stone; Robert L Sutherland
Journal:  Nat Rev Cancer       Date:  2011-07-07       Impact factor: 60.716

4.  PP2A (Cdc)⁵⁵ is required for multiple events during meiosis I.

Authors:  Jocelyn K Nolt; Lyndi M Rice; Christina Gallo-Ebert; Margaret E Bisher; Joseph T Nickels
Journal:  Cell Cycle       Date:  2011-05-01       Impact factor: 4.534

Review 5.  Phosphatases: providing safe passage through mitotic exit.

Authors:  Claudia Wurzenberger; Daniel W Gerlich
Journal:  Nat Rev Mol Cell Biol       Date:  2011-07-13       Impact factor: 94.444

Review 6.  Signaling pathways that regulate cell division.

Authors:  Nicholas Rhind; Paul Russell
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-10-01       Impact factor: 10.005

Review 7.  PP1 and PP2A phosphatases--cooperating partners in modulating retinoblastoma protein activation.

Authors:  Victoria Kolupaeva; Veerle Janssens
Journal:  FEBS J       Date:  2012-02-29       Impact factor: 5.542

8.  SCF ubiquitin ligases in the maintenance of genome stability.

Authors:  Joshua S Silverman; Jeffrey R Skaar; Michele Pagano
Journal:  Trends Biochem Sci       Date:  2011-11-16       Impact factor: 13.807

Review 9.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

Review 10.  Nuclear cyclin D1: an oncogenic driver in human cancer.

Authors:  Jong Kyong Kim; J Alan Diehl
Journal:  J Cell Physiol       Date:  2009-08       Impact factor: 6.384

View more
  7 in total

1.  PP2A-B55β antagonizes cyclin E1 proteolysis and promotes its dysregulation in cancer.

Authors:  Yingmeei Tan; Dahui Sun; Weijian Jiang; Kathleen Klotz-Noack; Ajay A Vashisht; James Wohlschlegel; Martin Widschwendter; Charles Spruck
Journal:  Cancer Res       Date:  2014-02-07       Impact factor: 12.701

2.  The PP2A-B56 Phosphatase Opposes Cyclin E Autocatalytic Degradation via Site-Specific Dephosphorylation.

Authors:  Ryan J Davis; Jherek Swanger; Bridget T Hughes; Bruce E Clurman
Journal:  Mol Cell Biol       Date:  2017-03-31       Impact factor: 4.272

3.  Morphogenesis checkpoint kinase Swe1 is the executor of lipolysis-dependent cell-cycle progression.

Authors:  Neha Chauhan; Myriam Visram; Alvaro Cristobal-Sarramian; Florian Sarkleti; Sepp D Kohlwein
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

4.  PP2A(Cdc55/B55), a possible therapeutic target in cyclin D1-dependent cancers.

Authors:  Eishi Noguchi
Journal:  Cell Cycle       Date:  2013-04-29       Impact factor: 4.534

5.  The G2 checkpoint-a node-based molecular switch.

Authors:  Mark C de Gooijer; Arnout van den Top; Irena Bockaj; Jos H Beijnen; Thomas Würdinger; Olaf van Tellingen
Journal:  FEBS Open Bio       Date:  2017-03-04       Impact factor: 2.693

Review 6.  Protein Phosphatases in G1 Regulation.

Authors:  Ruth Martín; Vilte Stonyte; Sandra Lopez-Aviles
Journal:  Int J Mol Sci       Date:  2020-01-08       Impact factor: 5.923

Review 7.  From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies.

Authors:  Maria Ciccone; George A Calin; Danilo Perrotti
Journal:  Front Oncol       Date:  2015-02-16       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.